✦ LIBER ✦

221 A phase II trial to assess the safety and immunological activity of TroVax plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma. The SKOPOS trial

✍ Scribed by Lester, J.F.; Casbard, A.; Roberts, K.; Tabi, Z.; Griffiths, G.

Book ID: 122554891
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 51 KB
Volume: 83
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(14)70221-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin in combination with irinotecan

Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma : A pilot phase II clinical trial and pharmacokinetic profile

✍ Takashi Nakano; A. Philippe Chahinian; Miho Shinjo; Naoki Togawa; Atsushi Tonomu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

The purpose of this study was to assess the efficacy and toxicity of a combination of cisplatin and irinotecan (CPT-11) in the treatment of patients with malignant pleural mesothelioma and to characterize the pharmacokinetic profiles of CPT-11 and its active metabolite, 7-ethyl-10-hydroxycamptotheci

P-401 Evaluating improvement in patient-

P-401 Evaluating improvement in patient-reported dyspnea and pulmonary function tests (PFTs) in patients with malignant pleural mesothelioma (MPM): An analysis as part of the 448-patient randomized pemetrexed + cisplatin versus cisplatin trial

✍ Gralla, R.; Symanowski, J.; Boyer, M.; Paoletti, P.; Rusthoven, J.; Manegold, C. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 298 KB

113 POSTER Phase II trial to assess the

113 POSTER Phase II trial to assess the activity of MVA5T4 (Trovax®) alone versus MVA5T4 plus granulocyte macrophage colony-stimulating factor (GM-CSF) in patients (pts) with progressive hormone refractory prostate cancer (HRPC)

✍ R. Amato; M. Karediy; A. Cao; M. Khan; S. Naylor; M. McDonald; R. Harrop; W. Shi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase II trial to assess the safety and

Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia

✍ Martínez-Cuadrón, David; Montesinos, Pau; Oriol, Albert; Salamero, Olga; Vidrial 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 102 KB

Combination chemotherapy with Cisplatin

Combination chemotherapy with Cisplatin (CDDP) and Adriamycin (ADM) plus immunotherapy with interferon (IFN) alfa-2b in malignant pleural mesothelioma (MPM): results of a phase II trial of the Italian Group on Rare Tumors (GITR) and Italian Lung Cancer Task Force (FONICAP)

✍ Parra, H.Soto; Bretti, S.; Ardizzoni, A.; Tixi, L.; Latteri, F.; Gravina, A.; Li 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 167 KB

8702 ORAL A Phase II, Multicenter, Clini

8702 ORAL A Phase II, Multicenter, Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab Alone in Japanese Patients With Recurrent Malignant Glioma

✍ Matsutani, M.; Nishikawa, R.; Kobayashi, H.; Takano, S.; Shinoura, N.; Nagane, M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB